New Indication: Trelegy Ellipta - Clinical Pain Advisor

New Indication: Trelegy Ellipta

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

Trelegy Ellipta is now approved for the maintenance treatment of asthma in patients aged 18 years and older.

Learn more about this new indication with our slideshow, complete drug monograph, and downloadable PDF.

This article originally appeared on MPR

Next hm-slideshow in Uncategorized